This inventor holds 1 USPTO granted patent. Top assignees: Duke University, Zeneca Limited. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2,078 
1 out of 854 
Years Active: 1999
Title: Angus T DeSouza: Innovator in Tumor Suppressor Research
Introduction
Angus T DeSouza is a notable inventor based in London, GB. He has made significant contributions to the field of cancer research, particularly in the area of tumor suppressor genes. His work has implications for both diagnostic and therapeutic approaches in oncology.
Latest Patents
DeSouza holds a patent for the M6P/IGF-II receptor tumor suppressor gene. This invention relates to a tumor suppressor and focuses on the mannose 6-phosphate/insulin-like growth factor-II (M6P/IGF-II) receptor. The patent outlines innovative diagnostic and therapeutic approaches based on this receptor, which could enhance cancer treatment strategies. He has 1 patent to his name.
Career Highlights
Throughout his career, Angus T DeSouza has worked with prestigious institutions, including Duke University and Zeneca Limited. His research has contributed to a deeper understanding of tumor biology and the mechanisms of cancer progression.
Collaborations
DeSouza has collaborated with notable colleagues such as Randy L Jirtle and Gerald R Hankins. These partnerships have furthered his research and expanded the impact of his work in the scientific community.
Conclusion
Angus T DeSouza is a prominent figure in the field of tumor suppressor research, with a focus on innovative approaches to cancer treatment. His contributions through patents and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile